161 related articles for article (PubMed ID: 22951096)
1. Emerging real-time technologies in molecular medicine and the evolution of integrated 'pharmacomics' approaches to personalized medicine and drug discovery.
Milward EA; Daneshi N; Johnstone DM
Pharmacol Ther; 2012 Dec; 136(3):295-304. PubMed ID: 22951096
[TBL] [Abstract][Full Text] [Related]
2. Understanding human diseases with high-throughput quantitative measurement and analysis of molecular signatures.
Yang L; Wei G; Tang K; Nardini C; Han JD
Sci China Life Sci; 2013 Mar; 56(3):213-9. PubMed ID: 23526386
[TBL] [Abstract][Full Text] [Related]
3. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
4. Genomic medicine frontier in human solid tumors: prospects and challenges.
Dienstmann R; Rodon J; Barretina J; Tabernero J
J Clin Oncol; 2013 May; 31(15):1874-84. PubMed ID: 23589551
[TBL] [Abstract][Full Text] [Related]
5. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
Ahmed MU; Saaem I; Wu PC; Brown AS
Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309
[TBL] [Abstract][Full Text] [Related]
6. Chemical proteomics and its impact on the drug discovery process.
Miao Q; Zhang CC; Kast J
Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
[TBL] [Abstract][Full Text] [Related]
7. The application of next-generation sequencing technologies to drug discovery and development.
Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
[TBL] [Abstract][Full Text] [Related]
8. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
Baudhuin LM; Donato LJ; Uphoff TS
Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
[TBL] [Abstract][Full Text] [Related]
9. What is next for small-molecule drug discovery?
Doweyko AM; Doweyko LM
Future Med Chem; 2009 Sep; 1(6):1029-36. PubMed ID: 21425992
[TBL] [Abstract][Full Text] [Related]
10. Towards an integrated venomics approach for accelerated conopeptide discovery.
Prashanth JR; Lewis RJ; Dutertre S
Toxicon; 2012 Sep; 60(4):470-7. PubMed ID: 22564717
[TBL] [Abstract][Full Text] [Related]
11. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
[TBL] [Abstract][Full Text] [Related]
12. Proteomics and systems biology: application in drug discovery and development.
Chakravarti B; Mallik B; Chakravarti DN
Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
[TBL] [Abstract][Full Text] [Related]
13. A window into third-generation sequencing.
Schadt EE; Turner S; Kasarskis A
Hum Mol Genet; 2010 Oct; 19(R2):R227-40. PubMed ID: 20858600
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery and delivery in the 21st century.
Triggle DJ
Med Princ Pract; 2007; 16(1):1-14. PubMed ID: 17159357
[TBL] [Abstract][Full Text] [Related]
15. Phosphoproteomics in drug discovery.
Morris MK; Chi A; Melas IN; Alexopoulos LG
Drug Discov Today; 2014 Apr; 19(4):425-32. PubMed ID: 24141136
[TBL] [Abstract][Full Text] [Related]
16. Analytical metabolomics: nutritional opportunities for personalized health.
McNiven EM; German JB; Slupsky CM
J Nutr Biochem; 2011 Nov; 22(11):995-1002. PubMed ID: 21999844
[TBL] [Abstract][Full Text] [Related]
17. Medicine. Personalized cancer diagnostics.
Corless CL
Science; 2011 Dec; 334(6060):1217-8. PubMed ID: 22144608
[No Abstract] [Full Text] [Related]
18. [Proteoforms: Methods of Analysis and Clinical Prospects].
Kiseleva OI; Lisitsa AV; Poverennaya EV
Mol Biol (Mosk); 2018; 52(3):394-410. PubMed ID: 29989573
[TBL] [Abstract][Full Text] [Related]
19. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
Zhang A; Sun H; Wang P; Han Y; Wang X
Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
[TBL] [Abstract][Full Text] [Related]
20. A challenging drug development process in the era of personalized medicine.
Jørgensen JT
Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
